547 related articles for article (PubMed ID: 10686432)
1. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
2. [Experimental investigation on the etiology and pathogenesis of pituitary prolactin-secreting tumor].
Wu XM
Sheng Li Ke Xue Jin Zhan; 2000 Jan; 31(1):43-6. PubMed ID: 12532766
[TBL] [Abstract][Full Text] [Related]
3. [Expression of prolactin, TGF alpha and TGF beta 1 genes in estrogen-induced eutopic and ectopic pituitary prolactin-secreting tumors of rats].
Wu XM; Xu JP; Zhang R; Xu RK
Sheng Li Xue Bao; 1999 Dec; 51(6):675-80. PubMed ID: 11498938
[TBL] [Abstract][Full Text] [Related]
4. [E2-induced prolactin-secreting tumor of heteroplasty pituitary in renal capsule of the rats].
Wu X; Zhang R; Xu R; Zhou Y; Di A
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):257-63. PubMed ID: 11367688
[TBL] [Abstract][Full Text] [Related]
5. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
Gao L; Yang QH; Xu RK
Sheng Li Xue Bao; 2005 Jun; 57(3):319-27. PubMed ID: 15968426
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of different mutations in regulatory sequence of prolactin gene during the formation of 17 beta-estradiol-induced prolactinoma in eutopic and ectopic pituitary of rats].
Zhang FZ; Yang QH; Mao YC; Xu RK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):822-7. PubMed ID: 17260475
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats.
Yang QH; Xu JN; Xu RK; Pang SF
J Pineal Res; 2006 Apr; 40(3):230-5. PubMed ID: 16499559
[TBL] [Abstract][Full Text] [Related]
8. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
9. [Melatonin suppressing the proliferation of E2-induced pituitary prolactin-secreting tumor in rat involves the effects of estrogen receptor].
Yang QH; Xu JN; Zhang R; Gao L; Xu RK
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 May; 22(2):174-8. PubMed ID: 21162234
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro.
Yang QH; Xu JN; Xu RK; Pang SF
J Pineal Res; 2007 Mar; 42(2):172-9. PubMed ID: 17286750
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta regulation of estradiol-induced prolactinomas.
Hentges S; Sarkar DK
Front Neuroendocrinol; 2001 Oct; 22(4):340-63. PubMed ID: 11587556
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription.
Shimon I; Hüttner A; Said J; Spirina OM; Melmed S
J Clin Invest; 1996 Jan; 97(1):187-95. PubMed ID: 8550832
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.
Ben-Shlomo A; Miklovsky I; Ren SG; Yong WH; Heaney AP; Culler MD; Melmed S
J Clin Endocrinol Metab; 2003 Feb; 88(2):858-63. PubMed ID: 12574225
[TBL] [Abstract][Full Text] [Related]
14. Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas.
McAndrew J; Paterson AJ; Asa SL; McCarthy KJ; Kudlow JE
Endocrinology; 1995 Oct; 136(10):4479-88. PubMed ID: 7664668
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of melatonin on the development of 17-beta-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents].
Gao L; Xu JP; Shan HM; Zhang R; Xu RK
Sheng Li Xue Bao; 2001 Jun; 53(3):165-9. PubMed ID: 12589398
[TBL] [Abstract][Full Text] [Related]
16. The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas.
Recouvreux MV; Camilletti MA; Rifkin DB; Díaz-Torga G
J Endocrinol; 2016 Mar; 228(3):R73-83. PubMed ID: 26698564
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of prolactinomas.
Spada A; Mantovani G; Lania A
Pituitary; 2005; 8(1):7-15. PubMed ID: 16411063
[TBL] [Abstract][Full Text] [Related]
18. mPRs represent a novel target for PRL inhibition in experimental prolactinomas.
Camilletti MA; Abeledo-Machado A; Perez PA; Faraoni EY; De Fino F; Rulli SB; Ferraris J; Pisera D; Gutierrez S; Thomas P; Díaz-Torga G
Endocr Relat Cancer; 2019 May; 26(5):497-510. PubMed ID: 30856609
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of melatonin on the development of pituitary prolactin-producing tumors induced by 17-beta-estradiol].
Gao L; Xu RK; Pang CS; Xu JP; Shan HM; Pang SF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):49-53. PubMed ID: 12905818
[TBL] [Abstract][Full Text] [Related]
20. Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice.
Hentges ST; Low MJ
Endocrinology; 2002 Dec; 143(12):4536-43. PubMed ID: 12446580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
